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Abstract Employing a spin trapping agent combined with elec-
tron spin resonance spectroscopy, we were able to capture re-
active oxygen species (ROS) in living hepatoma cells and ¢rst
found that the trapped ROS was superoxide anion (Oc32 ). O
c3
2
suppressed by treatment with diphenylene iodonium, a £avopro-
tein inhibitor, was generated by the £avoprotein-containing
NADPH-oxidase complex. Applying endogenous/exogenous
pro-oxidant or antioxidant causes di¡erent redox states in hep-
atoma cells. Akt activity and cell growth were signi¢cantly
stimulated by treating hepatoma cells with low concentration
of ROS, which could be abolished by adding antioxidants.
The phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin
(0.15 WM) inhibited Akt phosphorylation induced by ROS. Our
results indicate that hepatoma cell growth is ROS-dependent,
and £uctuation of the intracellular redox state may regulate
hepatoma cell growth through Akt phosphorylation and the
PI3K/Akt pathway, resulting in a broad array of responses
from cellular proliferation to apoptosis.
3 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Cellular redox phenomena are involved in numerous bio-
logical and biochemical processes. Reactive oxygen species
(ROS), by-products of respiration in aerobic organisms, are
highly reactive and can oxidize and modify other intracellular
molecules. ROS are formed from both exogenous and endog-
enous sources, includes superoxide anion (Oc32 ), hydrogen per-
oxide (H2O2), and hydroxyl anion (cOH). Endogenous ROS
are generated in cells by reducing antioxidants, or directly
induced by oxidants/oxidases. A link between intracellular
redox balance and growth control has long been implied [1].
Previous studies have indicated that low concentrations of
ROS can compensatorily enhance antioxidative enzyme activ-
ity [2] and promote cell proliferation, but high concentrations
of ROS will induce apoptosis [3^5].
Recently, ROS were recognized as modulators of receptor-
mediated signal transduction in a variety of cell types [6^8].
ROS can be a secondary messenger in cell signaling, and the
signal transduction pathway may activate protein kinase.
However, there is still no direct proof that ROS can mediate
hepatoma cell growth.
The evidence on cell growth indicates that the serine-threo-
nine kinase Akt/protein kinase B (PKB) is a critical enzyme in
a cell survival pathway. Akt activated by phosphorylation has
been shown to protect cells from apoptosis that is induced by
external stimuli in di¡erent cell types [9,10]. Oxidative stress,
antioxidant treatment and the Akt pathway have been shown
to play an important role in the regulation of cell growth;
however, the relationship between the phosphatidylinositol
3-kinase (PI3K)/Akt signal pathway and the intracellular
redox state is still unclear. It is, therefore, of interest to in-
vestigate whether £uctuation of the intracellular redox state
regulates cell proliferation and apoptosis via Akt phosphory-
lation and the PI3K/Akt signal pathway, which might provide
new strategies in regulating hepatoma cell growth and trigger-
ing the apoptosis process.
In the present study, ROS were used to induce oxidative
stress, and the levels of antioxidants further give rise to a
reduced interference state in hepatoma cells. In this paper
we studied the e¡ects of redox state £uctuation on cell growth,
and the relationship between this in£uence and Akt phosphor-
ylation.
2. Materials and methods
2.1. Materials
TRIzol reagent was obtained from Gibco BRL. TES, penicillin,
streptomycin, rabbit phospho-Akt (Thr308), Akt antibody, horserad-
ish peroxide-conjugated goat anti-rabbit antibody, and the PI3K in-
hibitor wortmannin were from Calbiochem. [3H]Thymidine was pur-
chased from Amersham Life Sciences. L-Carotene, diphenylene
iodonium (DPI) and N-acetyl L-cysteine (NAC) were obtained from
Sigma. Salvia miltriorrhiza (SM) was provided by the Pharmacology
School of Fudan University.
The 7721 human hepatoma cell line was obtained from Shanghai
Institute of Cell Biology, Chinese Academy of Sciences. The PHLA-
SOD(+) and PHLA-SOD(3) constructs containing sense or antisense
cDNA of human manganese superoxide dismutase (MnSOD) respec-
tively were generously provided by Prof. Kunitaka Hirose.
2.2. Cell culture and transfection
7721 hepatoma cells were grown in RPMI 1640 medium containing
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10% fetal calf serum, 100 mg/l streptomycin, 100 U/ml penicillin. The
sense MnSOD(+) and antisense MnSOD(3) constructs were trans-
fected into hepatoma cells using a standard method [11].
2.3. Cell treatment and incorporation of [3H]thymidine
7721 cells, PHLA-SOD(+) transfected cells (MnSOD-7721) and
PHLA-SOD(3) transfected cells (MnSOD-AS7721) were treated
with normal saline, Tween-8, oxygen stress (1 or 10 WM H2O2) or
antioxidants including catalase (5 U/ml), L-carotene (100 Wmol/l, dis-
solved in Tween-8), NAC (20 mmol/l) and SM (40 mg/l). SM can
scavenge superoxide and hydroxy radicals [12,13]. Cells were har-
vested at 2, 4, and 6 days after treatment.
Cell cycle progression was monitored by [3H]thymidine incorpora-
tion. Cells were incubated with [3H]thymidine (1 WCi/ml) for 4 h.
Total cell DNA was collected on Whatman GF/C ¢lter paper using
an automated cell harvester, and incorporated radioactivity was de-
termined by liquid scintillation counting [14].
2.4. Determination of cell apoptosis
The percentage of apoptotic cells was analyzed by £ow cytometer.
Cells were washed with phosphate-bu¡ered saline (PBS) and ¢xed
with 75% alcohol at 320‡C overnight. Then splitting solution was
added, and the cells were left stationary for 45 min at room temper-
ature, digested by RNase A (50 Wg/ml) for 10 min, and determined
with £ow cytometer (B.D Company of America). Cells below G1
phase were considered apoptotic cells [5].
2.5. Spin trapping and analysis of ROS in living hepatoma cells
ROS released from hepatoma cells were assessed directly using a
spin trapping agent combined with electron spin resonance (ESR)
spectroscopy. 10 Wl 0.1 mol/l spin trap, 5,5-dimethyl-1-pyrroline-N-
oxide (DMPO) was added to 90 Wl suspension of 7721 hepatoma cells,
and it was transferred to a £at quartz ESR aqueous cell, which was
¢xed in the cavity of the ESR spectrometer. ESR measurements were
carried out on an X-band ESR spectrometer (Bruker-IBM ER 200D-
SRC, Germany) under the following experimental conditions:
TE=300 K, SP=20 mV, SF=9.66 GHz, MA=2 G, CF=3420,
SW=100 G. The sample was scanned and accumulated 10 times for
20 min. SOD or DPI was then added and analyzed as described
above.
2.6. E¡ect of redox state on Akt phosphorylation
Cells (including 7721, MnSOD-7721 and MnSOD-AS7721) at 75^
85% con£uence in 75 mm dishes were made quiescent by incubation
with RPMI 1640 containing 0.1% calf serum for 24 h. Part of 7721
hepatoma cells were treated with exogenous H2O2 (10 WM) and anti-
oxidant SM (40 mg/l) for 12 h, respectively, while others were pre-
incubated with wortmannin (0^0.15 WM) for 1 h before exposure to
H2O2 (10 WM, 30 min). Total Akt level and Akt phosphorylation were
analyzed by Western blotting [15].
3. Results
3.1. Oc32 are trapped in living hepatoma cells
We used DMPO as a spin trap agent to capture the ROS in
Fig. 1. Spin trapping and ESR spectroscopy. ESR spectra of 7721
hepatoma cells were recorded with the spin trap DMPO on 5U106
cells with a Bruker-IBM ER 200D-SRC spectrometer. A: 7721 hep-
atoma cells displayed a 1:2:2:1 DMPO-OH quartet signal. B: 7721
hepatoma cells treated with SOD (100 U/ml) abolished the free radi-
cal signal. C: 7721 hepatoma cells treated with DPI (20 Wmol/l)
abolished the free radical signal.
                         
 
 
 
 
Fig. 2. E¡ects of redox state on 7721 hepatoma cell proliferation.
A: ROS generation in three cell lines. Hepatoma cells were washed
three times with PBS, then incubated with DCF-DA (5 WM) at
37‡C for 30 min. All cell concentrations were set to 1U106 cells/ml.
The £uorescence was measured by a £uorescence spectrometer
(F-3000, Hitachi) using an excitation wavelength of 488 nm and an
emission wavelength of 525 nm. Results are expressed as absolute
level of £uorescence (arbitrary units). B: Relative [3H]thymidine in-
corporation in vector-7721, MnSOD-7721 and MnSOD-AS7721
cells. Cells cultured for 2, 4, and 6 days were incubated with
[3H]thymidine (1 WCi/ml) for 4 h, [3H]thymidine incorporation was
assayed as described in Section 2. C: Relative [3H]thymidine incor-
poration in 7721 hepatoma cells which were treated with 1 WM or
10 WM H2O2 ; values are the meansSS.D. for three independent ex-
periments. *P6 0.05 compared to control cells.
FEBS 27180 22-4-03
S. Dong-Yun et al./FEBS Letters 542 (2003) 60^64 61
living hepatoma cells. It showed that cells displayed a 1:2:2:1
quartet signal (with KH=KN=14.9 G) indicative of DMPO-
OH adduct, indicating that the free radical signal in hepatoma
cells was successfully captured (Fig. 1A). The DMPO-OH
adduct can be performed either by direct trapping of cOH
or by rapid breakdown of DMPO-OOH, the adduct formed
by Oc32 . SOD, a speci¢c scavenger of O
c3
2 , quenched the cap-
tured signal of free radicals (Fig. 1B), which suggested the
ESR signal was made from Oc32 ; meanwhile SOD suppressed
DNA synthesis and hepatoma cell growth, whereas catalase
did not have these e¡ects. The result further suggested that
the free radical signal was attributable to Oc32 trapping rather
than to cOH derived from H2O2 in hepatoma cells, and was
capable of mediating DNA synthesis and cell growth.
To determine the source of Oc32 , we treated hepatoma
cells with DPI, a potent and highly selective £avoprotein in-
hibitor. The DMPO-OH signal was diminished in DPI-treated
hepatoma cells (Fig. 1C), which indicates that Oc32 was gen-
erated from the £avoprotein-containing NADPH-oxidase
complex.
3.2. Oxidative state stimulates hepatoma cell proliferation
Intracellular ROS levels were measured using the peroxide-
sensitive £uorophore dichlorodihydro£uorescein diacetate
(DCF-DA) as described by Jakubowski et al. [16]. The oxida-
tion of DCF-DA was signi¢cantly augmented in MnSOD-
AS7721 cells, there was a signi¢cant (about two-fold) en-
hancement of DCF compared with the control (vector-7721
cells) ; in contrast, the oxidation of DCF in MnSOD-7721
cells was reduced about 60% compared to the control (Fig.
2A). Upregulation of MnSOD expression in MnSOD-7721
cells decreased the intracellular oxidative levels, and down-
regulation of MnSOD expression in MnSOD-AS7721 cells
increased the intracellular oxidative levels [17]. The DNA syn-
thesis in these cells showed that overexpression of the
MnSOD gene suppressed cell proliferation and downregula-
tion of MnSOD expression stimulated cell proliferation (Fig.
2B). This ¢nding demonstrates that oxidative state could af-
fect cell growth, and cell proliferation was drastically sup-
pressed by reducing endogenous ROS level. In addition, exog-
enous H2O2 (1 or 10 WM) also stimulated cell growth (Fig.
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Fig. 3. E¡ects of antioxidants on hepatoma cells. A: The inhibitory e¡ect of antioxidants on hepatoma cell proliferation. 7721 hepatoma cells
were treated with antioxidants for 6 days, then incubated with [3H]thymidine (1 WCi/ml) for 4 h, [3H]thymidine incorporation was assayed as
described in Section 2. B: The e¡ect of antioxidants on hepatoma cell apoptosis. 7721 hepatoma cells were treated with antioxidants for 6 days,
then apoptosis was detected by £ow cytometry (FCM, B.D Company of America). C: Dose response of apoptosis by antioxidant SM in hepa-
toma cells. 7721 hepatoma cells were treated with (1) 0 mM, (2) 40 mM SM, or (3) 60 mM SM for 6 days, then related nuclear DNA contents
were measured by £ow cytometry. The percentage of apoptotic cells in (1)^(3) was 0%, 10.96%, 18.7%, respectively. Values are the meansSS.D.
for three independent experiments. *P6 0.05 compared to control cells.
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2C), but the exogenous antioxidant SM (40 mg/l) inhibited
cell proliferation (data not shown). This ¢nding indicates
that the intracellular oxidative state could regulate hepatoma
cell proliferation.
3.3. Antioxidants inhibit hepatoma cell growth and induce
apoptosis
To further study the role of antioxidants in hepatoma cell
growth, various antioxidants were applied to 7721 hepatoma
cells. The results indicate that antioxidants inhibited DNA
synthesis in hepatoma cells to di¡erent extents (Fig. 3A);
meanwhile, the percentage of apoptotic cells in the antioxi-
dant interference groups increased signi¢cantly (Fig. 3B) de-
pending on the dose of SM (Fig. 3C). Therefore, antioxidant
interference could not only inhibit hepatoma cell proliferation
but also induce apoptosis. It suggests that upregulation of the
reduction level may regulate cell growth and suppress the
e¡ect of ROS on hepatoma cell growth and apoptosis.
3.4. Redox state regulates Akt phosphorylation via the
PI3K-dependent pathway
To understand the mechanism of how antioxidants induce
apoptosis in hepatoma cells, we examined the e¡ects of exog-
enous and endogenous ROS on phosphorylation of Akt. As
shown in Fig. 4A (lanes 2, 3), H2O2 (10 WM) could stimulate
Akt phosphorylation, but signi¢cantly decreased the phos-
phorylation when the antioxidant SM (40 mg/l) added. In
addition, we found that upregulation of MnSOD expression
inhibited Akt phosphorylation, while downregulation of
MnSOD expression induced Akt phosphorylation (Fig. 4A,
lanes 5, 6). Proliferation of hepatoma cells increased upon
Akt phosphorylation, but was suppressed upon Akt dephos-
phorylation. Exogenous and endogenous ROS could thus reg-
ulate cell growth by regulating Akt phosphorylation; however
the mechanism of Akt phosphorylation induced by ROS is
still unclear. In this work, Akt phosphorylation was enhanced
when 7721 cells were treated with 10 WM H2O2. When 7721
cells were pretreated with wortmannin (a PI3K inhibitor) for
1 h before H2O2 stimulation, wortmannin dose-dependently
blocked Akt phosphorylation which was induced by ROS
(Fig. 4B, top); however, the total levels of Akt were steady
in various redox states (Fig. 4B, bottom). This suggests that
£uctuation of redox state regulates Akt phosphorylation
through a PI3K-dependent pathway.
4. Discussion
Previous studies have indicated that redox state plays a
crucial role in carcinogenesis of hepatoma and other cell types
[18^20]. It was found that patients with liver cancer or other
neoplastic disease have a chaotic antioxidative system. When
antioxidants such as vitamin E, vitamin C, vitamin A or some
natural antioxidants were used to assist the treatment, e¡ects
were signi¢cant such as lowering the level of lipid peroxides
and decreasing the infection rate of the liver after operation
[21,22]. It was reported that L-carotene possesses potent anti-
tumor activity. In the model of chemically induced rat liver
cancer, the animals fed L-carotene for a long period of time
before the treatment with the chemical toxin had a signi¢-
cantly lower incidence rate of cancer [23,24]. Our previous
study also indicated that antioxidants were protective against
tumors inoculated at the mouse’s axilla [3,5,25]. However, it is
still unclear why antioxidant interference can inhibit cancer
initiation and progression.
The accumulation of ROS in the body could increase the
intracellular oxidative level, leading to a state of oxidative
stress, which might further result in the chaotic cellular me-
tabolism involved in various diseases processes. Using antioxi-
dant interference or enhancing the level of antioxidase to
scavenge intracellular ROS can enhance the intracellular re-
ductive level and regulate the intracellular redox state to a
new balance, and the metabolism in the body will come to
order accordingly, which contributes to the prevention of var-
ious diseases initiated by cellular injury. Based on this evi-
dence, how to employ interference rationally to change the
redox state has attracted much attention in protective strat-
egies, modulating the function of tissue and cells so as to
prevent the initiation and progression of cancer.
It is known that some tumor cells produce ROS, but the
exact source of these products is unclear. To explore the role
of cellular redox state, we further determined the variety and
source of ROS generated in hepatoma cells. Employing a spin
trapping agent combined with ESR spectroscopy, we success-
fully captured ROS in living hepatoma cells. We ¢rst detected
Oc32 in 7721 human hepatoma cells and found it disappeared
by treatment with SOD or DPI. MnSOD-7721 hepatoma cells
showed that DNA synthesis was not active when the level of
free radicals was low. This suggested that Oc32 generated by
the £avoprotein-containing NADPH-oxidase complex may di-
rectly mediated DNA synthesis and cell proliferation in hep-
atoma.
Tumors can be initiated by many kinds of factors. ROS, an
important factor of initiating carcinogenesis, can modify
DNA structure, further leading to the mutation of onco-
gene/anti-oncogene, and ¢nally cause carcinogenesis. How-
ever, ROS can also act as essential intracellular secondary
 
 
 
          
             
 
 
 
Fig. 4. E¡ects of redox state on Akt phosphorylation. A: Akt phos-
phorylation in response to redox stress. Western blotting analysis of
cell extracts (50 Wg/lane) probed for Thr308 phosphorylated Akt,
the protein bands were detected by enhanced chemiluminescence
(ECL). Lanes 1^3: Akt phosphorylation in response to control,
antioxidant SM (40 mg/l) and H2O2 (10 WM) induction for 12 h;
lanes 4^6: Akt phosphorylation in vector-7721, MnSOD-7721 and
MnSOD-AS7721 cells. B: Dose response of Akt phosphorylation by
the PI3K inhibitor wortmannin in H2O2-induced hepatoma cells.
7721 hepatoma cells were preincubated with wortmannin (0^0.15
WM) for 1 h before exposure to H2O2 (10 WM, 30 min), and cell ex-
tracts (50 Wg/lane) were analyzed by probing for Thr308 phosphory-
lated Akt (top) and total Akt levels (bottom). Total Akt levels were
similar in various lanes.
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messengers in regulation of protein kinase activity, relative
gene expression, and in modulating cell growth, apoptosis,
di¡erentiation and transformation [26]. The activity of protein
kinase is associated with its reversible phosphorylation. Can-
cer cells usually have a lower reductive level and a higher
oxidative level, which causes an imbalance in the intracellular
redox state. Therefore, £uctuation of the redox state may
regulate speci¢c protein phosphorylation and further modu-
late hepatoma cell growth.
Recent evidence indicates that the serine-threonine kinase
Akt/PKB mediates many of the downstream events controlled
by PI3K. Following activation of PI3K, Akt isoforms are
recruited from the cytosol to the plasma membrane through
their interaction with secondary messengers such as phospha-
tidylinositol 3,4,5-triphosphate and/or phosphatidylinositol
3,4-bisphosphate, where they are thought to undergo a con-
formational change and the Thr308 residue is exposed, which
becomes easily activated by phosphorylation [27]. Our study
demonstrated that exogenous and endogenous ROS could im-
prove Akt phosphorylation leading to hepatoma cell prolifer-
ation, while PI3K inhibitor or antioxidants could suppress
Akt phosphorylation resulting in hepatoma cell apoptosis.
Therefore, intracellular redox state £uctuation may regulate
hepatoma cell growth through reversible Akt phosphorylation
and the PI3K/Akt pathway.
Employing endogenous and exogenous redox interference,
we have observed the e¡ects of redox state on Akt phosphor-
ylation and the expression of the related genes. Our experi-
ments suggested that upregulation of intracellular oxidative
level by a low concentration of H2O2 or antisense MnSOD
transfection resulted in an increase of cellular DNA synthesis,
Akt phosphorylation and AP-1 transcript factor subunit
c-Fos/c-Jun expression (data not shown). In contrast, down-
regulation of the oxidative level by antioxidant interference or
sense MnSOD transfection resulted in a decrease of cellular
DNA synthesis, AP-1 transcript factor expression and Akt
phosphorylation, but an increase of hepatoma cell apoptosis.
Employing various doses of SM, we found the antioxidant-
induced apoptosis of hepatoma cells was dose-dependent. The
data suggest that the PI3K/Akt pathway may be involved in
the regulation of redox state which plays an important role in
the growth of hepatoma cells and apoptosis.
In conclusion, our study showed that hepatoma cell growth
was ROS-dependent, and endogenous and exogenous ROS or
antioxidant interference were capable of regulating Akt phos-
phorylation through inhibiting Akt phosphorylation and de-
creasing c-Fos/c-Jun expression so as to suppress hepatoma
cell proliferation, or induce apoptosis. This ¢nding further
stresses the role of redox state in regulating cancer initiation
and progression, and exhibits a broad perspective of antioxi-
dant interference in cancer prevention and therapy.
Acknowledgements: This work was supported by Key Program Grant
30130100 of the National Natural Science Foundation, Grant
B990805 of the Shanghai Educational Committee and Grant
01JC14017 of the Shanghai Natural Science Foundation.
References
[1] Droge, W., Schulze-Ostho¡, K., Mihm, S., Galter, D., Schenk,
H., Eck, H.P., Roth, S. and Gmunder, H. (1994) FASEB J. 8,
1131^1138.
[2] Liu, S.L., Shi, D.Y., Pan, J.H. and Yao, S.K. (1998) Med. Sci.
Res. 26, 741^743.
[3] Liu, S.L., Shi, D.Y., Pan, X.H. and Shen, Z.H. (2001) Acta Bio-
chim. Biophys. Sin. 33, 463^466.
[4] Rutault, K., Alderman, C., Chain, B.M. and Katz, D.R. (1999)
Free Radic. Biol. Med. 26, 232^238.
[5] Liu, S.L., Shia, D., Liu, G., Chen, H., Liu, S. and Hu, Y. (2000)
Life Sci. 68, 603^610.
[6] Suzuki, Y.J., Forman, H.J. and Sevanian, A. (1997) Free Radic.
Biol. Med. 22, 269^285.
[7] Wolin, M.S. (2000) Arterioscler. Thromb. Vasc. Biol. 20, 1430^
1442.
[8] Finkel, T. (2000) FEBS Lett. 476, 52^58.
[9] Mathieu, A.L., Gonin, S., Leverrier, Y., Blanquier, B., Thomas,
J., Dantin, C., Martin, G., Baverel, G. and Marvel, J. (2001)
J. Biol. Chem. 276, 10935^10942.
[10] Liu, J., Yang, C.F., Wasser, S., Shen, H.M., Tan, C.E. and Ong,
C.N. (2001) Life Sci. 69, 309^326.
[11] Suresh, A., Tung, F., Moreb, J. and Zucali, J.R. (1994) Cancer
Gene Ther. 1, 85^90.
[12] Zhao, B.L., Jiang, W., Zhao, Y., Hou, J.W. and Xin, W.J. (1996)
Biochem. Mol. Biol. Int. 38, 1171^1182.
[13] von Gise, A., Lorenz, P., Wellbrock, C., Hemmings, B., Berbe-
rich-Siebelt, F., Rapp, U.R. and Troppmair, J. (2001) Mol. Cell.
Biol. 21, 2324^2336.
[14] Ebner, S., Dunbar, M. and McKinnon, R.D. (2000) J. Neurosci.
Res. 62, 336^345.
[15] Souza, K., Maddock, D.A., Zhang, Q., Chen, J., Chiu, C., Meh-
ta, S. and Wan, Y. (2001) Mol. Med. 7, 767^772.
[16] Jakubowski, W. and Bartosz, G. (2000) Cell Biol. Int. 24, 757^
760.
[17] Liu, S.L., Liu, G.Z., Cheng, J., Shi, D.Y., Cheng, H.L. and
Zhang, Y.D. (2002) Acta Biochim. Biophys. Sin. 34, 67^72.
[18] Skrzydewska, E., Stankiewicz, A., Michalak, K., Sulkowska, M.,
Zalewski, B. and Piotrowski, Z. (2001) Histochem. Cytobiol. 39,
98^99.
[19] Kovacic, P. and Jacintho, J.D. (2001) Curr. Med. Chem. 8, 773^
796.
[20] Ahmed, M.I., Fayed, S.T., Hossein, H. and Tash, F.M. (1999)
Dis. Markers 15, 283^291.
[21] Factor, V.M., Laskowska, D., Jensen, M.R., Woitach, J.T., Po-
pescu, N.C. and Thorgeirsson, S.S. (2000) Proc. Natl. Acad. Sci.
USA 97, 2196^2201.
[22] Woodson, K., Triantos, S., Hartman, T., Taylor, P.R., Virtamo,
J. and Albanes, D. (2002) Anticancer Res. 22, 375^378.
[23] Sarkar, A., Bishayee, A. and Chatterjee, M. (1995) Cancer Bio-
chem. Biophys. 15, 111^125.
[24] Bishayee, A., Sarkar, A. and Chatterjee, M. (2000) Nutr. Cancer
37, 89^98.
[25] Liu, S.L., Shi, D.Y., Shen, Z.H. and Wu, Y.D. (2000) Acta
Pharmacol. Sin. 21, 668^672.
[26] Liu, S.L., Lin, X., Shi, D.Y., Cheng, J., Wu, C.Q. and Zhang,
Y.D. (2002) Arch. Biochem. Biophys. 406, 173^182.
[27] Anderson, K.E., Coadwell, J., Stephens, L.R. and Hawkins, P.T.
(1998) Curr. Biol. 8, 684^691.
FEBS 27180 22-4-03
S. Dong-Yun et al./FEBS Letters 542 (2003) 60^6464
